[Dextran versus subcutaneous heparin in the prevention of deep venous thrombosis (D.V.T.) after biliary surgery].
Rosell Pradas
J
J
Vara-Thorbeck
R
R
D000328:Adult; D002763:Cholecystectomy / Q000009:adverse effects; D003911:Dextrans / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000517:prevention & control; D011897:Random Allocation; D013924:Thrombophlebitis / Q000209:etiology / Q000517:prevention & control*
D003911:Dextrans; D006493:Heparin
Dextran "versus" heparina subcutánea en la profilaxis de la trombosis venosa profunda (T.V.P.) postcirugía biliar.